These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22775300)

  • 1. The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis.
    Nieman DH; Velthorst E; Becker HE; de Haan L; Dingemans PM; Linszen DH; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; von Reventlow HG; Morrison A; Schultze-Lutter F; Klosterkötter J; Ruhrmann S;
    Acta Psychiatr Scand; 2013 Jan; 127(1):53-61. PubMed ID: 22775300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
    Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
    Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study.
    Parellada M; Castro-Fornieles J; Gonzalez-Pinto A; Pina-Camacho L; Moreno D; Rapado-Castro M; Otero S; de la Serna E; Moreno C; Baeza I; Graell M; Arango C
    J Clin Psychiatry; 2015 Nov; 76(11):e1441-8. PubMed ID: 26580481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.
    Addington J; Liu L; Perkins DO; Carrion RE; Keefe RS; Woods SW
    Schizophr Bull; 2017 Jan; 43(1):57-63. PubMed ID: 27798225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up.
    Salokangas RK; Nieman DH; Heinimaa M; Svirskis T; Luutonen S; From T; von Reventlow HG; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J; Ruhrmann S;
    Soc Psychiatry Psychiatr Epidemiol; 2013 Feb; 48(2):303-11. PubMed ID: 22797132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis.
    Bearden CE; Wu KN; Caplan R; Cannon TD
    J Am Acad Child Adolesc Psychiatry; 2011 Jul; 50(7):669-80. PubMed ID: 21703494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Movement disorders as a prodromal sign in individuals at high risk of psychosis].
    van Harten PN; Bakker PR; van Os J
    Tijdschr Psychiatr; 2015; 57(2):77-82. PubMed ID: 25669942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metacognitive functioning predicts positive and negative symptoms over 12 months in first episode psychosis.
    McLeod HJ; Gumley AI; Macbeth A; Schwannauer M; Lysaker PH
    J Psychiatr Res; 2014 Jul; 54():109-15. PubMed ID: 24725651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk.
    Dragt S; Nieman DH; Veltman D; Becker HE; van de Fliert R; de Haan L; Linszen DH
    Schizophr Res; 2011 Jan; 125(1):69-76. PubMed ID: 20884179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.
    De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M
    Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis.
    Kotlicka-Antczak M; Pawełczyk A; Karbownik MS; Pawełczyk T; Strzelecki D; Żurner N; Urban-Kowalczyk M
    Schizophr Res; 2017 Mar; 181():49-54. PubMed ID: 27765522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up.
    Saeedi H; Addington J; Addington D
    Schizophr Res; 2007 Jan; 89(1-3):123-8. PubMed ID: 17097272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study.
    van Tricht MJ; Ruhrmann S; Arns M; Müller R; Bodatsch M; Velthorst E; Koelman JH; Bour LJ; Zurek K; Schultze-Lutter F; Klosterkötter J; Linszen DH; de Haan L; Brockhaus-Dumke A; Nieman DH
    Schizophr Res; 2014 Mar; 153(1-3):42-7. PubMed ID: 24508483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.
    Brewer WJ; Francey SM; Wood SJ; Jackson HJ; Pantelis C; Phillips LJ; Yung AR; Anderson VA; McGorry PD
    Am J Psychiatry; 2005 Jan; 162(1):71-8. PubMed ID: 15625204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.